Delivery Order SPE2DB22D3004-SPE2DB25FRS41
Award Date 7/30/25
Potential Completion Date 7/31/25
Potential Value $1.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for $1,416.30 to supply ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The contract is classified as a firm fixed price delivery order with no set-aside designation, indicating competitive award, and is scheduled for completion by July 31, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,751.90 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,124.45 to AmerisourceBergen Drug Corp for the supply of ENGERIX-B PEDI 10 MCG/0.5 ml syringes on July 23, 2025, with completion targeted for July 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. ENGERIX-B is a hepatitis B vaccine commonly used in pediatric immunization...
- The Defense Logistics Agency awarded a delivery order valued at $1,734.75 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine (20 micrograms per milliliter syringes). This competitively awarded, firm fixed-price delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is a child contract under...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine supply, valued at $18,567.90 under a firm fixed price structure. This non-set-aside award was executed on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,255.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The order is for the delivery of pediatric hepatitis B vaccine and has a period of performance from July 10-11, 2023. As the DLA supports all Department of Defense branches, this order is likely associated with the agency's medical supply chain...
- The Defense Logistics Agency awarded a delivery order valued at $2,713.02 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML syringes, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of the company's role as a critical pharmaceutical supplier to federal healthcare systems. The contract was executed on July 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $22,886.40 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine supply. This firm fixed price contract, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery...
- The Defense Logistics Agency awarded a $28,321.00 delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with an ultimate completion date of July 30, 2025. This competitive, firm fixed-price delivery order was issued with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a $681.74 delivery order contract to Amerisourcebergen Drug Corporation for ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML. The firm fixed price contract has a period of performance from July 11, 2023 through July 12, 2023. Amerisourcebergen will deliver the pediatric hepatitis B vaccine to its Conshohocken, Pennsylvania location in support of the Defense Logistics Agency's medical supply chain responsibilities. No major subcontractors or set aside designations were...